The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes
Authors:
- Delphine BorchielliniDBDelphine Borchiellini
- Marie-Christine Etienne-GrimaldiMEMarie-Christine Etienne-Grimaldi
- Juliette ThariatJTJuliette Thariat
- Gérard MilanoGMGérard Milano
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 38 (6) , 737-759
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 ProteinJournal of Biological Chemistry, 2011
- The ERCC1 N118N polymorphism does not change cellular ERCC1 protein expression or platinum sensitivityMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated With the Development of Erectile Dysfunction in African-American Men After Radiotherapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Functions of disordered regions in mammalian early base excision repair proteinsCellular and Molecular Life Sciences, 2010
- Genomewide Association Studies and Assessment of the Risk of DiseaseNew England Journal of Medicine, 2010
- Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesisNature Reviews Molecular Cell Biology, 2010
- Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case‐control studyInternational Journal of Cancer, 2009
- Genetic Susceptibility to CancerJAMA, 2008
- Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapyBritish Journal of Cancer, 2006